FDA Inspection 1114388 — Luoyang MuChun Pharmaceutical Co., Ltd.
The FDA completed an inspection of Luoyang MuChun Pharmaceutical Co., Ltd. on December 6, 2019 in Yanshi City. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- December 6, 2019
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Yanshi City (China)